Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Hicks

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
The American Journal of Surgical Pathology|September 2, 2011
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomasLuciana Schultz, Alcides Chaux, Roula Albadine, et al.
The Lancet. Microbe|December 27, 2025
Strengthening hepatitis B virus clinical research in Africa: the need for multistakeholder collaboration, funding, and political willMitchell Leus, Chukwunomso E Osakwe, Danjuma Adda, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2022
Expanding community engagement and advocacy in chronic viral hepatitisEneyi E Kpokiri, Dalia Elasi, Tiange P Zhang, et al.
Transplantation and Cellular Therapy|December 8, 2021
Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study ReportAman Wadhwa, Yanjun Chen, Lindsey Hageman, et al.
Applied and Environmental Microbiology|October 11, 2023
Concurrent colonization of rodent kidneys with multiple species and serogroups of pathogenic <i>Leptospira</i>Camila Hamond, Karen LeCount, A Springer Browne, et al.
The Journal of Pathology|October 15, 2021
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancerJanielle P Maynard, Jiayun Lu, Igor Vidal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaHsueh-Li Tan, Akshay Sood, Hameed A Rahimi, et al.
Cancer Research|November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneitySrinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.
The American Journal of Surgical Pathology|August 2, 2007
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrumPedram Argani, Semra Olgac, Satish K Tickoo, et al.
European Urology|August 2, 2016
Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical ProstatectomyJeffrey J Tosoian, Fawaz Almutairi, Carlos L Morais, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|September 2, 2011
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomasLuciana Schultz, Alcides Chaux, Roula Albadine, et al.
The Lancet. Microbe|December 27, 2025
Strengthening hepatitis B virus clinical research in Africa: the need for multistakeholder collaboration, funding, and political willMitchell Leus, Chukwunomso E Osakwe, Danjuma Adda, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2022
Expanding community engagement and advocacy in chronic viral hepatitisEneyi E Kpokiri, Dalia Elasi, Tiange P Zhang, et al.
Transplantation and Cellular Therapy|December 8, 2021
Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study ReportAman Wadhwa, Yanjun Chen, Lindsey Hageman, et al.
Applied and Environmental Microbiology|October 11, 2023
Concurrent colonization of rodent kidneys with multiple species and serogroups of pathogenic <i>Leptospira</i>Camila Hamond, Karen LeCount, A Springer Browne, et al.
The Journal of Pathology|October 15, 2021
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancerJanielle P Maynard, Jiayun Lu, Igor Vidal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaHsueh-Li Tan, Akshay Sood, Hameed A Rahimi, et al.
Cancer Research|November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneitySrinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.
The American Journal of Surgical Pathology|August 2, 2007
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrumPedram Argani, Semra Olgac, Satish K Tickoo, et al.
European Urology|August 2, 2016
Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical ProstatectomyJeffrey J Tosoian, Fawaz Almutairi, Carlos L Morais, et al.
Pageof 12